NathanABergerMD

Hematology • Cleveland, OH

Professor, Medicine, Case Western Reserve University School of Medicine

Join to view full profile

Dr. Berger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Berger's full profile

Already have an account?

Office
Case Western Reserve University School of Medicine
10900 Euclid Ave Health Sciences Library
Cleveland, OH 44106
Phone+1 216-844-3951

Fax+1 216-368-3244

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1967 - 1968
Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1966 - 1967
Drexel University College of MedicineClass of 1966

Certifications & Licensure

OH State Medical License 1983 - 2025

Awards, Honors, & Recognition

Elected Member The American Society for Clinical Investigation, 1980

Clinical Trials

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients Start of enrollment: 2023 Mar 20
Recruiting
Not Applicable
Roles: Contact, Principal Investigator

Publications & Presentations

PubMed

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes.
Lindsey Wang, Rong Xu, David C Kaelber, Nathan A Berger
JAMA Network Open. 2024-07-01
23 citations
GLP-1 Receptor Agonists and Colorectal Cancer Risk in Drug-Naive Patients With Type 2 Diabetes, With and Without Overweight/Obesity.
Lindsey Wang, William Wang, David C Kaelber, Rong Xu, Nathan A Berger
JAMA Oncology. 2024-02-01
138 citations
Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity.
Ali Aminian, Rickesha Wilson, Abbas Al-Kurd, Chao Tu, Alex Milinovich
JAMA. 2022-06-28

Press Mentions

Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated CancersJuly 5th, 2024
Learning About Breakthrough Covid: Vaccines Deter Long Covid but Breakthrough Risks Higher for Cancer, Alzheimer’s PatientsJune 8th, 2022
Obesity a Major Factor in Rising Rates of Cancer in Young AdultsApril 4th, 2018
Join now to see all

Grant Support

Genetic Determinants Of Barrett'S Esophagus And Esophageal AdenocarcinomaNational Cancer Institute2011
Case Center For Transdisciplinary Research On Energetics And CancerNational Cancer Institute2007–2010
BioassaysNational Cancer Institute2005–2009
Aacr-Trec-Nih Think TANK Conference: Energy Balance And Cancer;Mechanisms And MENational Cancer Institute2008
Aging-Cancer Research Program Development At Cwru CCCNational Cancer Institute2003–2007
Case Center For Transdisciplinary Research On Energetic*National Cancer Institute2006
Transdisciplinary Research On Energetics And CancerNational Cancer Institute2005
Faculty RecruitmentNational Cancer Institute2005
AdministrationNational Cancer Institute2005
General Clinical Research CenterNational Center For Research Resources1996–2002
Short Term Training For Minority Students ProgramNational Heart, Lung, And Blood Institute1997–2001
Phase II Trials Of TOPO I InhibitorsNational Cancer Institute1994–2000
Gcrc-Cap-Dr SpiroNational Center For Research Resources1997
Developing And Improving Institutional Animal ResourcesNational Center For Research Resources1997
Modulation-Alkylating Agent Chemotherapy-Colon CancerNational Cancer Institute1994–1996
Phase II Trials Of Topoisomerase I InhibitorsNational Cancer Institute1995
Modulation/Alkylating Agent Chemotherapy--Colon CancerNational Cancer Institute1995
Receptor-Targeted Protein Toxins For Brain Tumor TherapyNational Cancer Institute1993–1995
Cwru Cancer Research CenterNational Cancer Institute1993–1995
Alkylating Agent Chemotherapy And Colon CancerNational Cancer Institute1994
Cancer Screening Education For Older Minority AdultsNational Cancer Institute1992–1994
Modulation--Alkylating Agent Chemotherapy-Colon CancerNational Cancer Institute1991–1993
Cancer Research CenterNational Cancer Institute1992
Case Western Reserve University Cancer Research CenterNational Cancer Institute1987–1991
Poly(Adpr) Polymerase Inhibitors In Cancer TherapyNational Cancer Institute1986–1987
Poly (ADPR) In Genetic Disorders Of DNA RepairNational Institute Of General Medical Sciences1985–1986